Sodium Sulfacetamide, Sulfur NDC 69367-244

NDC codes

FDA NDC Directory

Product NDC (as listed)69367-244Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69367-0244Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69367-244-10	69367024410	285 g in 1 BOTTLE (69367-244-10)Marketed from May 5, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sodium Sulfacetamide, Sulfur
Generic name (nonproprietary): sulfacetamide sodium and sulfur
Active ingredients: Sulfacetamide sodium — 98 mg/gSulfur — 48 mg/g
Dosage form: Liquid
Route: Topical
Labeler: Westminster Pharmaceuticals, LLC
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: May 5, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Sulfonamides (Chemical structure)
Identifiers: Product ID 69367-244_4fe0b59c-b850-44db-9670-a7499c724feaSPL ID 4fe0b59c-b850-44db-9670-a7499c724feaSPL set ID 4478ac49-8984-42db-9b9e-bea6346a6955RxCUI 1494169UNII 4NRT660KJQ, 70FD1KFU70
Pharmacologic class: Sulfonamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469367024410 followed by a unit qualifier and the quantity

Package 69367-0244-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 21, 2020.

Indications (excerpt from the label)

INDICATIONS This product is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)